학술논문
Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
Document Type
Article
Source
In Bone February 2014 59:44-52
Subject
Language
ISSN
8756-3282